SEC Form 4 · accession 0001250853-15-000060
SELLAS Life Sciences Group, Inc. · SLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven A Kriegsman
Director
Period of report
Jun 19, 2015
Accepted (ET)
Jun 23, 2015 · 8:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001390478
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $1.77 | Jun 19, 2015 | A | 100,000 | A | — | Jun 19, 2025 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The Issuer's Board of Directors approved the stock option grant on April 17, 2015, subject to stockholder approval of an amendment to the Amended and Restated 2007 Incentive Plan of the Issuer (the "Plan") to increase the number of shares of common stock available under the Plan. The Issuer's stockholders approved such amendment on June 19, 2015.
- F2The stock option vests in four equal quarterly installments over a period of one year beginning three months after June 19, 2015.